Good Works II Acquisition Corp. (GWII) Merger with Direct Biologics (Private)
October 14, 2022 Earnout Securities consist of: Valuation Milestone Shares of Class B Common Stock of Company TopCo and Direct Biologics Up-C Units $50 million Triggering Event I Achieve a primary efficacy endpoint of 60-day all-cause mortality in its Phase 3 EXTINGuish trial by December 31, 2023 Shares of Class B Common Stock of Company …
Good Works II Acquisition Corp. (GWII) Merger with Direct Biologics (Private) Read More »